Diagnostic Microbiology & Infectious Disease
Volume 67, Issue 2 , Pages 172-179 , June 2010

Quantitative detection and typing of hepatitis D virus in human serum by real-time polymerase chain reaction and melting curve analysis

  • Joerg Hofmann

      Affiliations

    • Institute of Medical Virology, Helmut-Ruska-Haus, Charité Universitätsmedizin, D-10117 Berlin, Germany
    • Corresponding Author InformationCorresponding author. Institute of Medical Virology, Helmut-Ruska-Haus, Charité University Medicine Berlin, Charitéplatz 1, 10117 Berlin, Germany. Tel.: +49-30450525141; fax: +49-30450525141.
  • ,
  • Katrin Frenzel

      Affiliations

    • Institute of Medical Virology, Helmut-Ruska-Haus, Charité Universitätsmedizin, D-10117 Berlin, Germany
  • ,
  • Bui Q. Minh

      Affiliations

    • Center for Integrative Bioinformatics Vienna (CIBIV), Max F. Perutz Laboratories (MFPL), University of Vienna, Medical University of Vienna, University of Veterinary Medicine, A-1210 Vienna, Austria
  • ,
  • Arndt von Haeseler

      Affiliations

    • Center for Integrative Bioinformatics Vienna (CIBIV), Max F. Perutz Laboratories (MFPL), University of Vienna, Medical University of Vienna, University of Veterinary Medicine, A-1210 Vienna, Austria
  • ,
  • Anke Edelmann

      Affiliations

    • Institute of Medical Virology, Helmut-Ruska-Haus, Charité Universitätsmedizin, D-10117 Berlin, Germany
  • ,
  • Stefan R. Ross

      Affiliations

    • Institute of Virology, Essen Universitätskrankenhaus, University of Duisburg-Essen, D-45141 Essen, Germany
  • ,
  • Thomas Berg

      Affiliations

    • Klinik und Poliklinik für Gastroenterologie and Rheumatologie Universitätsklinikum Leipzig AöR, D-04006 Leipzog, Germany
  • ,
  • Detlev H. Krüger

      Affiliations

    • Institute of Medical Virology, Helmut-Ruska-Haus, Charité Universitätsmedizin, D-10117 Berlin, Germany
  • ,
  • Helga Meisel

      Affiliations

    • Institute of Medical Virology, Helmut-Ruska-Haus, Charité Universitätsmedizin, D-10117 Berlin, Germany

Received 2 November 2009 ,Accepted 2 February 2010.

References 

  1. Castelnau C, Le Gal F, Ripault MP, Gordien E, Martinot-Peignoux M, Boyer N, et al. Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up. Hepatology. 2006;44:728–735
  2. Chao M. RNA recombination in hepatitis delta virus: implications regarding the abilities of mammalian RNA polymerases. Virus Res. 2007;127:208–215
  3. Deny P. Hepatitis delta virus genetic variability: from genotypes I, II, III to eight major clades. Curr. Top. Microbiol. Immunol. 2006;307:151–171
  4. Dieye A, Obami-Itou V, Barry MF, Raphenon G, Thiam A, Ndiaye R, et al. Association between class I HLA alleles and HBs antigen carrier status among blood donors in Senegal. Dakar Med. 1999;44:166–170
  5. Do CB, Mahabhashyam MS, Brudno M, Batzoglou S. ProbCons: probabilistic consistency-based multiple sequence alignment. Genome Res. 2005;15:330–340
  6. Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004;32:1792–1797
  7. Erhardt A, Knuth R, Sagir A, Kirschberg O, Heintges T, Haussinger D. Socioepidemiological data on hepatitis delta in a German university clinic—increase in patients from Eastern Europe and the former Soviet Union. Z. Gastroenterol. 2003;41:523–526
  8. Erhardt A, Gerlich W, Starke C, Wend U, Donner A, Sagir A, et al. Treatment of chronic hepatitis delta with pegylated interferon-alpha2b. Liver Int. 2006;26:805–810
  9. Farci P. Delta hepatitis: an update. J. Hepatol. 2003;39(Suppl 1):S212–S219
  10. Fattovich G, Giustina G, Christensen E, Pantalena M, Zagni I, Realdi G, et al. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep). Gut. 2000;46:420–426
  11. Gaeta GB, Stroffolini T, Smedile A, Niro G, Mele A. Hepatitis delta in Europe: vanishing or refreshing?. Hepatology. 2007;46:1312–1313
  12. Hadziyannis SJ. Review: hepatitis delta. J. Gastroenterol. Hepatol. 1997;12:289–298
  13. Hopf U, Neuhaus P, Lobeck H, Konig V, Kuther S, Bauditz J, et al. Follow-up of recurrent hepatitis B and delta infection in liver allograft recipients after treatment with recombinant interferon-alpha. J. Hepatol. 1991;13:339–346
  14. Katoh K, Misawa K, Kuma K, Miyata T. MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res. 2002;30:3059–3066
  15. Lau DT, Doo E, Park Y, Kleiner DE, Schmid P, Kuhns MC, et al. Lamivudine for chronic delta hepatitis. Hepatology. 1999;30:546–549
  16. Lee CM, Bih FY, Chao YC, Govindarajan S, Lai MM. Evolution of hepatitis delta virus RNA during chronic infection. Virology. 1992;188:265–273
  17. Le Gal F, Gordien E, Affolabi D, Hanslik T, Alloui C, Deny P, et al. Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients. J. Clin. Microbiol. 2005;43:2363–2369
  18. Letunic I, Bork P. Interactive Tree Of Life (iTOL): an online tool for phylogenetic tree display and annotation. Bioinformatics. 2007;23:127–128
  19. Niro GA, Ciancio A, Tillman HL, Lagget M, Olivero A, Perri F, et al. Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study. Aliment. Pharmacol. Ther. 2005;22:227–232
  20. Notredame C, Higgins DG, Heringa J. T-Coffee: a novel method for fast and accurate multiple sequence alignment. J. Mol. Biol. 2000;302:205–217
  21. Radjef N, Gordien E, Ivaniushina V, Gault E, Anais P, Drugan T, et al. Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades. J. Virol. 2004;78:2537–2544
  22. Rizzetto M. Hepatitis D: thirty years after. J. Hepatol. 2009;50:1043–1050
  23. Rizzetto M, Canese MG, Gerin JL, London WT, Sly DL, Purcell RH. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J. Infect. Dis. 1980;141:590–602
  24. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. U. S. A. 1977;74:5463–5467
  25. Schmidt HA, Strimmer K, Vingron M, von Haeseler A. TREE-PUZZLE: maximum likelihood phylogenetic analysis using quartets and parallel computing. Bioinformatics. 2002;18:502–504
  26. Stamatakis A. RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics. 2006;22:2688–2690
  27. Stamatakis A, Hoover P, Rougemont J. A rapid bootstrap algorithm for the RAxML Web servers. Syst. Biol. 2008;57:758–771
  28. Tavare S. Some probabilistic and statistical problems on the analysis of DNA sequences. Lec. Math. Life Sci. 1986;17:57–86
  29. Taylor JM. Hepatitis delta virus. Virology. 2006;344:71–76
  30. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994;22:4673–4680
  31. Vinh lS, von Haeseler A. IQPNNI: moving fast through tree space and stopping in time. Mol. Biol. Evol. 2004;21:1565–1571
  32. Wallace IM, O'Sullivan O, Higgins DG, Notredame C. M-Coffee: combining multiple sequence alignment methods with T-Coffee. Nucleic Acids Res. 2006;34:1692–1699
  33. Wang TC, Chao M. RNA recombination of hepatitis delta virus in natural mixed-genotype infection and transfected cultured cells. J. Virol. 2005;79:2221–2229
  34. Watanabe H, Nagayama K, Enomoto N, Chinzei R, Yamashiro T, Izumi N, et al. Chronic hepatitis delta virus infection with genotype IIb variant is correlated with progressive liver disease. J. Gen. Virol. 2003;84:3275–3289
  35. Wu JC, Hsu SC, Wang SY, Huang YH, Sheen IJ, Shih HH, et al. “Defective” mutations of hepatitis D viruses in chronic hepatitis D patients. World J. Gastroenterol. 2005;11:1658–1662
  36. Yamashiro T, Nagayama K, Enomoto N, Watanabe H, Miyagi T, Nakasone H, et al. Quantitation of the level of hepatitis delta virus RNA in serum, by real-time polymerase chain reaction—and its possible correlation with the clinical stage of liver disease. J. Infect. Dis. 2004;189:1151–1157

PII: S0732-8893(10)00039-8

doi: 10.1016/j.diagmicrobio.2010.02.003

Diagnostic Microbiology & Infectious Disease
Volume 67, Issue 2 , Pages 172-179 , June 2010